Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018. | ||||||
Tychan is a Singapore-based clinical-stage biotechnology company developing monoclonal antibodies. | ||||||
Cerulean Pharma, Inc is a company founded in 2006 by Ram Sasisekharan. | ||||||
Visterra is a company founded by Ram Sasisekharan. | ||||||
Visterra Inc. is a company founded in 2007 by Kevin Bitterman. |